Maserati R - Search Results

1

Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART.

Baldanti F, Paolucci S, Gulminetti R, Maserati R, Migliorino G, Pan A, Maggiolo F, Comolli G, Chiesa A, Gerna G. Baldanti F, et al. Among authors: maserati r. Antiviral Res. 2001 Jun;50(3):197-206. doi: 10.1016/s0166-3542(01)00142-5. Antiviral Res. 2001. PMID: 11397507

2

Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART.

Paolucci S, Baldanti F, Maserati R, Castelli F, Suter F, Maggiolo F, Pan A, Gerna G. Paolucci S, et al. Among authors: maserati r. Antiviral Res. 2000 Feb;45(2):101-14. doi: 10.1016/s0166-3542(00)00062-0. Antiviral Res. 2000. PMID: 10809019

3

Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in HIV-infected patients.

Baldanti F, Paolucci S, Maserati R, Maggiolo F, Pan A, Castelli F, Gulminetti R, Comolli G, Chiesa A, Gerna G. Baldanti F, et al. Among authors: maserati r. Eur J Clin Microbiol Infect Dis. 2000 May;19(5):380-4. doi: 10.1007/s100960050499. Eur J Clin Microbiol Infect Dis. 2000. PMID: 10898142

4

Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.

Gerna G, Piccinini G, Genini E, Percivalle E, Zavattoni M, Lilleri D, Testa L, Comolli G, Maserati R, Baldanti F, Maccario R, Monforte AD, Revello MG. Gerna G, et al. Among authors: maserati r. J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):320-31. doi: 10.1097/00126334-200112010-00003. J Acquir Immune Defic Syndr. 2001. PMID: 11707667

5

Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells.

Lilleri D, Chiesa A, Fornara C, Maserati R, Lozza L, Comolli G, Gerna G. Lilleri D, et al. Among authors: maserati r. Clin Microbiol Infect. 2007 Jan;13(1):19-24. doi: 10.1111/j.1469-0691.2006.01557.x. Clin Microbiol Infect. 2007. PMID: 17184283 Free article.

6

Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors.

Seminari E, Maggiolo F, Villani P, Suter F, Pan A, Regazzi MB, Paolucci S, Baldanti F, Tinelli C, Maserati R. Seminari E, et al. Among authors: maserati r. J Acquir Immune Defic Syndr. 1999 Dec 15;22(5):453-60. doi: 10.1097/00126334-199912150-00005. J Acquir Immune Defic Syndr. 1999. PMID: 10961606 Clinical Trial.

7

Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz.

Maggiolo F, Migliorino M, Maserati R, Pan A, Rizzi M, Provettoni G, Rizzi L, Suter F; Once Study Group. Maggiolo F, et al. Among authors: maserati r. Antivir Ther. 2001 Dec;6(4):249-53. Antivir Ther. 2001. PMID: 11878406

8

Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.

Clerici M, Seminari E, Suter F, Castelli F, Pan A, Biasin M, Colombo F, Trabattoni D, Maggiolo F, Carosi G, Maserati R. Clerici M, et al. Among authors: maserati r. AIDS. 2000 Jan 28;14(2):109-16. doi: 10.1097/00002030-200001280-00005. AIDS. 2000. PMID: 10708280

9

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.

Paolucci S, Cassaniti I, Novazzi F, Fiorina L, Piralla A, Comolli G, Bruno R, Maserati R, Gulminetti R, Novati S, Mojoli F, Baldanti F; San Matteo Pavia COVID-19 Task Force. Paolucci S, et al. Among authors: maserati r. Int J Infect Dis. 2021 Mar;104:315-319. doi: 10.1016/j.ijid.2020.12.051. Epub 2020 Dec 21. Int J Infect Dis. 2021. PMID: 33359064 Free PMC article.

10

Antiviral potency of HAART regimens and clinical success are not strictly coupled in real life conditions: evidence from the MASTER-1 study.

Carosi G, Castelli F, Suter F, Maggiolo F, Orani AM, Pan A, Andreoni M, Vigevani GM, Maserati R, Mazzotta F, Tinelli C; MATER Study Group. Carosi G, et al. Among authors: maserati r. HIV Clin Trials. 2001 Sep-Oct;2(5):399-407. doi: 10.1310/5xcl-5xe9-jafk-xk7y. HIV Clin Trials. 2001. PMID: 11673814 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters